![]() |
|
|||
|
WASHINGTON -- Follow-up studies of a Roche breast cancer drug showed that it failed to extend the lives of patients, federal health scientists said Friday, opening the door for it to be potentially withdrawn for use in treating that disease.
|
| Thread Tools | |
| Display Modes | |
|
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Once promising breast cancer drug could get FDA boot | cancerfr | Lung Cancer | 0 | 09-06-2010 11:17 PM |
| Amgen: Vectibix fails in head and neck cancer test | cancerfr | Head and Neck Cancer | 0 | 08-13-2010 04:59 AM |
| FDA study shows breast cancer drug Avastin fails to slow cancer | cancerfr | Breast Cancer | 0 | 07-19-2010 07:41 PM |
| Study shows promising basis for development of effective liver-cancer screening test | cancerfr | Liver Cancer | 0 | 04-12-2010 03:05 PM |